LogicBio Therapeutics

About

LogicBio Therapeutics develops gene therapy vectors for previously incurable genetic and infectious diseases, including hemophilia, HIV/AIDS, and methylmalonic acidemia. The company's proprietary technology is based on the nonpathogenic adeno-associated viral vector. The technology may offer improved efficiency and safety, and it is well suited for the treatment of both children and adults.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsGenes

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

LogicBio Therapeutics — Full Company Profile (machine-readable)

Gene Therapy for Genetic and Infectious Diseases

About

Facts

Name	LogicBio Therapeutics
Slug	logicbio-therapeutics
Type	Israeli Startup
Founded	2016
HQ city	Ness Ziona
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Mature
Public stage	Mature
Total raised (USD)	119,000,000
Last round	Series B (2017-06)
Crunchbase ID	logicbio-therapeutics
Israeli Companies Registrar	515388817

Funding rounds (2)

Date	Round	Amount	Lead investors	All investors	Valuation
2016-01	Series A	$4,000,000		OrbiMed
2017-06	Series B	$45,000,000		SBI JI Innovation Fund, Pontifax, Arix Bioscience, Andera Partners, OrbiMed

Public offerings (1)

Date	Kind	Exchange	Ticker	Amount	Valuation
2018-10	ipo	NASDAQ	LOGC		$219.4M

Team (3)

Name	Role	LinkedIn
Adi Barzel
Mark Kay
Brittany DiCredico

News mentions (4)

Oct 21, 2018 — www.calcalistech.com: Article
Jun 28, 2017 — www.fiercebiotech.com: Article
Jun 28, 2017 — www.globes.co.il: Article
Jan 21, 2016 — medcitynews.com: Article

About

Funding history · 2 rounds · $119.0M total

Sectors & technology

Highlights

Tags